Industry Ignited Podcast · 2025-12-01 · 40 min
In this episode of Industry Ignited , Dr. Leeanne Aguilar interviews Dr. Laurie Myers, CEO of Hallett Davis Strategic Group , to unpack how science, ethics, and commercialization must intersect to deliver life-changing medicines. Dr. Myers shares her remarkable transition from toxicology research to senior marketing leadership at global pharma giants, revealing how listening, data translation, and ethical judgment drive successful product launches. She also discusses the future of AI in pharma, the growing importance of truth-verified data sources, lessons from mergers and acquisitions, and why resilience and flexibility remain essential for leaders navigating constant industry change. This conversation highlights the power of cross-functional expertise and why today’s pharmaceutical leaders must balance innovation with responsibility.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Timothy Smith on AI, Data, and Drug Discovery at TakedaPharma Sessions · on AI in Pharma78 / 100
Pharma’s Biggest Blind Spot: Why 99.9% of Chemical Space Was Never Explored | Dr. Olga Nissan, Ph.D. - Vice President of Business Development, EvogeneProgress, Potential, and Possibilities Podcast / Show · on AI in PharmaThis Surgical Innovation Solves a 50-Year-Old Problem | Ep. 98 [Will Crawford]80 / 100The Next Billion-Dollar Energy Opportunity | Ep. 92 [Andrew Stock]70 / 100How to Scale a Battery Energy Storage Company Without Failing | Ep. 91 [Mark Hagedorn]65 / 100How Manufacturers Are Cutting Energy Costs Without Spending a Dollar Upfront | Ep. 90 [David Kipling]71 / 100The Science Behind Nature-Inspired Innovation | Ep. 89 [Sidney Rostan]80 / 100